Literature DB >> 9674473

Beneficial effect of atrial natriuretic peptide on pulmonary gas exchange in patients with acute lung injury.

C Mitaka1, Y Hirata, T Nagura, Y Tsunoda, K Amaha.   

Abstract

STUDY
OBJECTIVES: The purpose of this study was to investigate the effect of i.v. infusion of atrial natriuretic peptide (ANP) on hemodynamics, pulmonary gas exchange, and urine volume during mechanical ventilation with positive end-expiratory pressure (PEEP) in patients with acute lung injury.
DESIGN: Prospective, randomized, comparable study.
SETTING: ICU of a university hospital. PATIENTS: Forty patients with moderate acute lung injury (lung injury score > or = 2.0) who required mechanical ventilation with PEEP were studied.
INTERVENTIONS: The patients were randomly divided into two groups: ANP group (n=20) and control group (n=20). The ANP group received genetic recombination alpha-human ANP (carperitide) at the rate of 0.1 microg/kg/min for 24 h. The control group did not receive ANP. MEASUREMENTS AND
RESULTS: Hemodynamic and blood gas parameters, and urine volume were measured at baseline, 3 h, and 24 h after initiating the ANP infusion. Plasma ANP concentrations markedly (p<0.01) increased from 112.0+/-27.0 to 1,868.3+/-385.3 pg/mL after 24 h in the ANP group, whereas they remained unchanged in the control group. In the ANP group, hemodynamic parameters did not change, but PaO2/FIO2 (fraction of inspired oxygen) and thoracic compliance significantly (p<0.01) increased at 24 h after initiating the ANP infusion, associated with significant (p<0.01) decreases in lung injury score and shunt. Urine volume significantly (p<0.01) increased during 0 to 3 h after initiating the ANP infusion. In the control group, hemodynamics, pulmonary gas exchange, and urine volume did not significantly change during the study period. There were significant differences in PaO2/FIO2 (24 h), thoracic compliance (24 h), lung injury score (24 h), and urine volume (3 h) between the two groups.
CONCLUSION: The results suggest that ANP infusion induces diuresis and improves pulmonary gas exchange in patients with acute lung injury during mechanical ventilation with PEEP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674473     DOI: 10.1378/chest.114.1.223

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

1.  Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1.

Authors:  Anna A Birukova; Junjie Xing; Panfeng Fu; Bakhtiyor Yakubov; Oleksii Dubrovskyi; Jennifer A Fortune; Alexander M Klibanov; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-20       Impact factor: 5.464

2.  Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury.

Authors:  Junjie Xing; Bakhtiyor Yakubov; Valeriy Poroyko; Anna A Birukova
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

3.  Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction.

Authors:  Junjie Xing; Nurgul Moldobaeva; Anna A Birukova
Journal:  J Appl Physiol (1985)       Date:  2010-11-04

4.  Low-dose carperitide (α-human A-type natriuretic peptide) alleviates hemoglobin concentration decrease during prolonged oral surgery: a randomized controlled study.

Authors:  Masanori Tsukamoto; Sayuri Koyama; Kanako Esaki; Takashi Hitosugi; Takeshi Yokoyama
Journal:  J Anesth       Date:  2017-01-30       Impact factor: 2.078

5.  Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.

Authors:  Yufeng Tian; Isa Mambetsariev; Nicolene Sarich; Fanyong Meng; Anna A Birukova
Journal:  Biochim Biophys Acta       Date:  2014-10-27

Review 6.  Endothelial actions of atrial and B-type natriuretic peptides.

Authors:  Michaela Kuhn
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Effectiveness of human atrial natriuretic peptide supplementation in pulmonary edema patients using the pulse contour cardiac output system.

Authors:  Yuichiro Sakamoto; Kunihiro Mashiko; Nobuyuki Saito; Hisashi Matsumoto; Yoshiaki Hara; Noriyoshi Kutsukata; Hiroyuki Yokota
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

8.  Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.

Authors:  Anna A Birukova; Tatiana Zagranichnaya; Elena Alekseeva; Gary M Bokoch; Konstantin G Birukov
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

Review 9.  Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

Authors:  Emily J Tsai; David A Kass
Journal:  Pharmacol Ther       Date:  2009-03-21       Impact factor: 12.310

10.  Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-A.

Authors:  James R Klinger; Shu-Whei Tsai; Sabrina Green; Katie L Grinnell; Jason T Machan; Elizabeth O Harrington
Journal:  J Appl Physiol (1985)       Date:  2012-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.